Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

BeCause Closes Seed Round with Tail-End Investment From Curiosity VC

Published

on

because-closes-seed-round-with-tail-end-investment-from-curiosity-vc

The AI-focused Firm Brings BeCause’s Total Seed Funding to $2.5M to Support the Sustainability Data Technology Company’s Growth

COPENHAGEN, Denmark, Feb. 22, 2024 /PRNewswire/ — BeCause, the Danish start-up transforming how the global hospitality, travel, and tourism industries manage their sustainability data, has secured a $600,000 (€556K) tail-end investment from Dutch investor Curiosity VC to close their seed round. This latest investment brings the company’s total seed funding to $2.5 million (€2.32M), including the $1.9 million (€1.76M) seed raised in November from Denmark’s Ugly Duckling Ventures, Estonia’s Superangel.io and other investors.

“We reserved some space at the end of our round for a strategic investor to join on equal terms and are thrilled to have found that partner in Curiosity VC. As an AI-focused fund, Curiosity brings key competencies and an international network to the table that will prove invaluable to us as we continue to unfold how artificial intelligence can enable more sustainability-focused operations in hospitality and tourism and across our growing set of solutions,” says BeCause co-founder and CEO Frederik Steensgaard.

Mission-Driven Growth

Using BeCause, hotels can fully automate the collection, analysis, and communication of their sustainability efforts through a centralized hub, making it much easier for properties to qualify for industry certifications like GreenKey and ensure regulatory compliance based on local frameworks. BeCause dramatically reduces the cost of repetitive and manual tasks by up to 60%, compared to the error-prone processes still widely used within the industry to manage sustainability data. This increase in efficiency and trust significantly improves operational effectiveness.

Hotels also gain critical insights into the types of sustainability investments that might be most valuable for their business and the planet while enabling them to leverage the growing consumer demand for sustainability-focused accommodations. Simultaneously/Finally, the platform allows travel marketplaces, like Booking.com, to get real-time information from green certification labels about a hotel’s sustainability status, which they can use to help travelers and customers make informed choices about their travel plans.

BeCause currently has over 20,000 hotels worldwide streaming sustainability data via its platform and counts more than 50 certifiers and 15 travel booking marketplaces amongst its users.

“What attracted us to BeCause is that they have a clear goal and a true passion for the problem at hand. Their advanced AI capabilities further enhance their ability to drive innovation, address complex challenges, and revolutionize sustainability efforts across sectors. Looking at how far they’ve already come, their execution powers are undeniable,” says Herman Kienhuis, Managing Partner at Curiosity VC. “They have a solid growth strategy in place and are perfectly positioned to solve the needs of stakeholders in hospitality, acting not just as a compliance tool, but as a strategic asset that opens improvement opportunities and aligns the industry with the evolving priorities of a more environmentally aware society.”

The now-completed seed round will enable BeCause to push ahead with its solution developed to support the European Union’s Corporate Sustainability Reporting Directive (CSRD), a pioneering regulation that strengthens the rules concerning ESG reporting for any company operating in the zone. Funding will also support the company’s accelerated growth rate to meet demand from global enterprise customers, such as Booking.com, easyJet, Google, Radisson Hotel Group, and other global marquee brands across the travel, tourism, and hospitality sectors.

“CSRD will transform how companies report on their sustainability. BeCause has a major role to play in ensuring hotels and tourism companies can seamlessly communicate their impact on people and the environment to their investors, governments, and the world,” Steensgaard adds. “We are grateful to our VC partners for believing in our vision and enabling us to meet the diverse needs of all our clients. Now it’s time to accelerate the future of sustainable tourism and hospitality.”

For more information about BeCause or to speak with CEO and Co-founder Frederik Steensgaard, please contact Vanessa Horwell at [email protected].

About BeCause
BeCause is an enterprise software company that streamlines the flow of sustainability data and creates synergies between different stakeholders in the travel, tourism, and hospitality industries, empowering them to make decisions that result in positive, responsible change for people, the planet, and their profits. BeCause works with over 20,000 hotels, including brands like Radisson, certification entities like GreenKey, industry partners like the Global Sustainable Tourism Council, and marketplaces like Booking.com. For more information, visit because.eco.

About Curiosity
Curiosity is an Amsterdam-based venture capital fund focused on early-stage investments in ambitious, diverse teams based in the Benelux, Nordics, and Baltics. The fund invests in AI-first software companies that create value for businesses and society. Curiosity is led by two experienced operator-investors, Herman Kienhuis and Maurice Beckand Verwee, supported by a community of expert advisors and portfolio company founders who all become co-owners of the fund. For more information, visit https://www.curiosityvc.com or email: [email protected].

View original content:https://www.prnewswire.co.uk/news-releases/because-closes-seed-round-with-tail-end-investment-from-curiosity-vc-302068266.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading

Trending